Basic Podofilm Information

• INN (International Nonproprietary Name): Podophyllotoxin (for pure, standardized form) and Podophyllum resin or Podophyllin (for crude resin extract).
• Brand Names Available In Canada (English): not specified.
• ATC Code: D06BB04.
• Forms & Dosages: Topical solutions (resin) 10%, 20%, 25% in 3–10 mL vials; topical cream/gel (podophyllotoxin) 0.5% in 3–5 g tubes.
• Manufacturers In Canada (English): not specified.
• Registration Status In Canada (English): not specified.
• OTC / Rx Classification: Prescription (Rx) only due to toxicity and risk of improper use.
• Standard Dosages & Regimens: Podophyllotoxin 0.5% gel/cream is self-applied twice daily for 3 days followed by 4 days off, repeat for up to 4 cycles; podophyllum resin 20–25% is for healthcare professional application once weekly with wash-off after 1–4 hours.
• Treatment Duration: Up to 4 treatment cycles for genital/anal warts; do not exceed 6 weeks continuous use.
• Missed Dose / Overdose: Skip missed dose and resume schedule; do not double dose; overdose may cause severe local irritation and rare systemic toxicity including GI, neurological symptoms and bone marrow suppression—seek immediate medical help.
• Storage & Transport: Store at 15–30°C, protect from light, keep out of reach of children; avoid extreme heat and keep in original container.
• Absolute Contraindications: Pregnancy (teratogenic, Category X), hypersensitivity to podophyllum or podophyllotoxin, application to mucosal membranes or open wounds, internal genitalia or inflamed skin.
• Relative Contraindications: HIV/AIDS, large or multiple lesions, poor skin barrier integrity such as eczema or psoriasis.
• Common Side Effects: Local burning, redness, swelling, itching, mild erosion or ulceration; rare systemic effects with excessive use include nausea, vomiting, diarrhoea, altered mental status and blood cell suppression.
• Competitors / Alternatives: Imiquimod (Aldara), cryotherapy, trichloroacetic acid and cantharidin.
• Clinical Pearls: Podophyllum resin is poisonous in high doses and should never be used over large areas; patient self-application is restricted to 0.5% podophyllotoxin gels; topical agents treat external warts but do not clear underlying HPV infection.

Latest Research Highlights (Canadian & International)

Worried whether podophyllotoxin still works for warts?

Recent studies from 2022–2025 continue to confirm that topical podophyllotoxin and podophyllum resin are effective for external anogenital and plantar warts when used as recommended.

Systematic reviews show higher clearance rates for podophyllotoxin 0.5% gel versus placebo and similar short-term efficacy compared with provider-applied resin in clinic settings.

Safety signals remain focused on local application-site irritation and rare systemic toxicity after misuse or excessive application.

Regulatory summaries from the US and EU continue to list approved products such as Condyline and Podofilox for topical wart treatment, and professional-use resin solutions at 10–25% remain in use.

Canadian case series since 2022 highlight extra caution in immunocompromised patients and in pregnant people where use is contraindicated.

Study Highlights

• Podophyllotoxin 0.5% gel shows higher clearance than placebo in pooled analyses.
• Provider-applied podophyllum resin (10–25%) produces rapid local necrosis and clearance but requires trained staff and careful application.
• Reports of systemic toxicity are rare and tied to large-area application or improper use.

Insert table here comparing pooled clearance rates and adverse-event frequencies: Canada versus EU versus India data.

Patients in Canada value clear risk communication and bilingual labelling, and remote communities often rely on nurse-practitioners for in-office resin application.

Clinical Effectiveness In Canada

Curious how these medicines perform in everyday Canadian practice?

Health Canada regulates topical wart agents and expects manufacturers to submit safety and efficacy data, while international approvals from FDA and EMA inform Canadian clinical practice when local trials are limited.

Real‑world dermatology audits in Canada show that podophyllotoxin 0.5% self-applied regimens achieve lesion clearance in many adults within four cycles when instructions are followed.

Professional 20–25% resin applications are used less often in Canada but work quickly by producing local necrosis; these applications require trained staff and clinic settings.

Topical wart agents are classed under ATC D06BB04 and are typically available as 0.5% gels/creams (podophyllotoxin) and 10–25% resin solutions.

Patients commonly ask about a Drug Identification Number (DIN) and whether provincial plans will cover therapy.

Most topical wart medications are prescription-only and are not routinely listed on provincial formularies such as ODB, BC PharmaCare or RAMQ.

Major pharmacy chains including Shoppers, Rexall, Jean Coutu and London Drugs dispense prescription topical wart medications, and rural clinics sometimes refer patients to public sexual health clinics.

Clinical Takeaways

• Expect podophyllotoxin 0.5% to be effective for many adult patients with external warts when used per product monograph.
• Reserve resin solutions for clinic-applied treatments due to higher irritation and toxicity risk.
• Confirm DIN and prescription status before dispensing; counsel about provincial coverage limits.

Indications And Expanded Uses

Not sure which lesions are appropriate for podophyllotoxin or resin?

International labelling limits podophyllotoxin and podophyllum resin to external wart lesions, including genital, perianal and plantar warts.

Evidence for off‑label dermatologic uses is limited and generally low-quality, and small case reports should not guide routine practice.

Resin solutions at 10–25% are for professional use only, while podophyllotoxin 0.5% gel/cream is intended for adult self-application.

In Canada, clinicians avoid prescribing these agents for pregnant people (absolute contraindication), children, or mucosal lesions.

Careful choices are advised for Indigenous and remote populations with limited follow-up; clinic-applied treatments reduce the risk of misuse.

Approved Indications

• External genital warts (condylomata acuminata).
• Perianal external warts.
• Plantar warts for professional resin use.

Off‑Label Uses

• Small case reports exist for other cutaneous lesions but carry increased risk and lack robust evidence.

High-Risk Scenarios To Avoid

• Pregnancy or suspected pregnancy.
• Application to mucosal surfaces or open wounds.
• Large-area or multiple lesion treatment without clinical supervision.

Table: Approved Age Groups And Contraindications

Composition And Brand Landscape

Wondering how Podofilm fits into the brand mix?

Products fall into two chemical categories: pure podophyllotoxin (0.5% gels/creams) and crude podophyllum resin (10–25% solutions) with different safety profiles.

Regional brand names vary: Condyline, Warticon and Wartec are common in the UK and EU for 0.5% formulations.

The USA and some Asian markets list resin products such as Podocon-25 and Podofin as 25% solutions, and names such as Podowart or Podofilox appear in India and SE Asia.

ATC classification is D06BB04 for podophyllotoxin / podophyllum resin topical agents.

In Canada, patients often search for brand names such as Podofilm, but Health Canada approval and a DIN should be verified prior to procurement.

Generics from global manufacturers like Mylan, Glenmark or Dr. Reddy’s may be available internationally, but domestic manufacturer listings in Canada are not specified in available data.

Table: Active Ingredient, Concentration, Packaging And Likely Canadian Availability

Patient Checklist When Verifying A Product

• Confirm a valid DIN on the package.
• Check for bilingual labelling (English/French) where possible.
• Verify storage instructions and expiry date.

Contraindications And Special Precautions

Worried about safety risks and who should not use these medicines?

Pregnancy is an absolute contraindication because podophyllotoxin and podophyllum resin are teratogenic and embryotoxic (Category X).

These products must not be applied to mucosal surfaces, open wounds or internal genitalia such as the vagina, cervix or rectum.

Hypersensitivity to podophyllum sources is an absolute contraindication.

Relative cautions include HIV/AIDS, very large or multiple lesions, and conditions that impair the skin barrier like eczema or psoriasis.

Systemic toxicity is rare but reported with excessive or inappropriate use and presents with gastrointestinal distress, altered mental status and bone marrow suppression.

Absolute Contraindications

• Pregnancy.
• Known hypersensitivity to podophyllum or podophyllotoxin.
• Application to mucosal membranes or open wounds.

Relative Contraindications

• Immunosuppression including HIV/AIDS.
• Large-area treatment or numerous lesions.
• Severe skin barrier disorders.

Data Highlight

Teratogenic Risk: Podophyllotoxin and podophyllum resin are Category X and must not be used during pregnancy.

Overdose Symptoms: Severe local pain with widespread erythema, nausea, vomiting, confusion or bleeding warrant urgent medical evaluation.

Dosage Guidelines (Canadian Focus)

Not sure how to apply podophyllotoxin safely at home?

Standard regimens used internationally are the reference for Canadian practice: podophyllotoxin 0.5% is self-applied twice daily for 3 days followed by 4 days off, up to 4 cycles.

Professional resin regimens use 20–25% solutions applied by a clinician once weekly and washed off after 1–4 hours.

Podophyllotoxin self-application should not exceed six weeks of continuous therapy.

Pharmacies in Canada emphasise written bilingual instructions and pharmacist counselling to reduce misuse, with telehealth follow-up for remote patients.

Stepwise Home Application (Podophyllotoxin 0.5% Gel)

• Wash and dry the affected area thoroughly before application.
• Apply a thin layer only to visible wart tissue; avoid surrounding healthy skin.
• Wash hands after applying unless hands are being treated.
• Follow the schedule: twice daily for 3 days, then 4 days off; repeat as directed up to four cycles.
• Stop and seek care for severe irritation, spreading redness or systemic symptoms.

Table: Professional Resin Regimen Versus Self-Care Podophyllotoxin Regimen

Interactions Overview

Worried that podophyllotoxin will interact with your other medicines?

Systemic drug–drug interactions are uncommon because topical podophyllotoxin has minimal systemic absorption under recommended use.

Interactions become relevant with excessive application or very large treated areas that could produce systemic exposure.

Reported systemic toxicity after overdose includes gastrointestinal symptoms, neurological changes and bone marrow suppression.

Concurrent use of topical irritants such as alcohol-based cleansers or other caustic agents can increase local skin injury.

Patients on systemic immunosuppressive drugs, including chemotherapy, may have altered healing and require specialist input before topical wart therapy.

Interaction Screening

• Ask about systemic immunomodulators, chemotherapy or significant hepatic disease before starting treatment.
• Query concurrent topical remedies, including traditional topical agents used by Indigenous or immigrant patients.
• Avoid combining with other caustic skin agents, alcohol-based cleansers or harsh exfoliants on the same area.

Definitions

• Topical Interaction Risk: Increased local irritation when multiple topical agents are used together.
• Systemic Interaction Risk: Rare; arises when excessive absorption produces systemic podophyllotoxin levels that may interact with systemic therapies.

Cultural Perceptions And Patient Habits

Worried about stigma, privacy and practical barriers to treatment?

Social research and patient forums in Canada show significant stigma around genital warts and a strong preference for discreet, private treatment options.

Many Canadians search online for Podofilm or Podowart as they look for convenient at‑home options.

Evidence suggests adherence improves when patients receive clear instructions and privacy assurances from pharmacists or clinicians.

Patients often prefer clinic-administered resin for perceived safety, but at-home 0.5% podophyllotoxin gel is chosen for convenience and privacy when access allows.

Rural and Northern communities face barriers including travel and limited pharmacy access, making bilingual (English/French) resources and culturally safe communication essential.

Common Patient Concerns

• Will treatment be discreet and confidential?
• How long until warts clear and will they return?
• Are there pregnancy risks or interactions with other medicines?

Counselling Phrases That Work

• "This medicine is for external warts only and must not be used during pregnancy."
• "Follow the written schedule exactly and contact your clinic if you get severe irritation."
• "If you live in a remote area, telehealth follow-up can help monitor reactions."

Data highlight: Telemedicine uptake for dermatologic and sexual-health concerns in Canada has increased, improving access for rural patients seeking wart treatment.

Availability And Pricing Patterns (Canada Vs US)

Trying to compare availability and cost across the border?

International supply patterns vary: 0.5% podophyllotoxin creams are common in the EU/UK, while resin solutions are commonly supplied in Asia and some US markets.

Brand and packaging differences include Condyline and Podofilox in EU/UK and Podocon-25 or Podofin for resin solutions in the USA.

In Canada, prescription status and DIN requirements mean OTC access is limited and patients generally require a prescription.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ rarely list podophyllotoxin for routine wart care, so most patients pay out-of-pocket.

Major pharmacy chains including Shoppers, Rexall, Jean Coutu and London Drugs dispense by prescription and will verify DIN and eligibility for exceptional coverage.

Cross-border shoppers sometimes compare US pricing, but strict prescription controls and safety oversight discourage importing without proper verification.

Table: Price / Access Comparison (Representative)

Safe Procurement Checklist

• Verify the product has a valid DIN when purchased in Canada.
• Check bilingual labelling and expiry date when ordering online.
• Avoid importing unless you have a verified prescription and supplier authentication.

Purchase note: In our online pharmacy, podofilm is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Comparable Medicines And Preferences

Wondering what alternatives exist if podophyllotoxin or resin aren’t right for you?

Effective alternatives include imiquimod (Aldara), cryotherapy with liquid nitrogen, trichloroacetic acid (TCA) and cantharidin.

Comparative trials show similar overall clearance rates across these options but different side‑effect profiles, costs and suitability for self-care versus clinic procedures.

Imiquimod is a prescription topical immune response modifier often used when patients prefer at-home therapy but it has a different tolerability profile compared with podophyllotoxin.

Cryotherapy and TCA are provider-administered, commonly offered through sexual-health clinics in Canada and suitable for patients who prefer clinic-based care or have contraindications to podophyllotoxin.

Table: Pros / Cons Checklist Comparing Common Options

Patient Preference Indicators

• Privacy: At-home podophyllotoxin or imiquimod preferred.
• Travel burden: Clinic procedures less feasible for remote patients.
• Cost concerns: Public sexual-health clinics may offer lower-cost options for cryotherapy or TCA.

FAQ Section (Canadian Patient-Style Q&A)

Looking for quick answers about Podofilm and similar products?

Q1: Is Podofilm available in Canada and do I need a prescription?

• Most podophyllotoxin and podophyllum products are prescription-only in Canada.
• Check the packaging for a Drug Identification Number (DIN).
• Contact your community pharmacy (Shoppers, Rexall, Jean Coutu, London Drugs) or sexual-health clinic for local access and advice.

Q2: Can I use Podofilm while pregnant?

• No — podophyllotoxin and podophyllum resin are teratogenic and are absolute contraindications during pregnancy (Category X).
• If pregnant or planning pregnancy, seek clinic-based alternatives and specialist advice.

Q3: Which Is Safer For Home Use — Resin Or 0.5% Gel?

• Resin solutions (10–25%) are intended for clinic application only.
• Podophyllotoxin 0.5% gel/cream is intended for patient self-application in adults.

Q4: Will Provincial Drug Plans Pay For It?

• Generally not routinely covered; check ODB, BC PharmaCare and RAMQ for exceptional listings.
• Expect out-of-pocket cost unless exceptional coverage applies.

Quick Actions And Contacts

• Contact a sexual-health clinic for low-cost clinic treatments such as cryotherapy or TCA.
• Ask your pharmacist to verify DIN and provide bilingual counselling.
• For severe reactions, seek urgent care or call local emergency services.

Guidelines For Proper Use — Pharmacist And Provincial Advice

Wondering what pharmacists should check before dispensing?

Best-practice guidelines stress trained application for resin, strict dosing schedules for podophyllotoxin 0.5% and clear written warnings about teratogenicity and local irritation.

Pharmacists should confirm a valid DIN, review bilingual instructions and counsel patients on storage (15–30°C) and safe handling.

Advise against application to large areas or damaged skin and instruct patients to stop treatment and seek care for severe local or systemic symptoms.

Provincial formularies such as ODB, BC PharmaCare and RAMQ may permit exceptional coverage for specific medical necessity; document clinical justification where needed.

For remote patients, telepharmacy follow-up is a practical option to monitor adverse reactions and improve adherence.

Pharmacist Step-By-Step

• Verify DIN and prescription validity.
• Explain the dosing schedule and demonstrate application technique if needed.
• Provide written bilingual instructions and red-flag symptoms to watch for.
• Arrange follow-up via telehealth for rural or remote patients.

Table: Storage / Transport And Emergency Contact Procedures

Delivery Across Canada (English)